<tt id="e4eee"></tt>
  • <li id="e4eee"></li>
    <li id="e4eee"><table id="e4eee"></table></li>
    <tt id="e4eee"><blockquote id="e4eee"></blockquote></tt>
  • <li id="e4eee"><table id="e4eee"></table></li>
    <tt id="e4eee"></tt>
  • <li id="e4eee"></li>
    首頁(yè) /藥靶模型 /免疫治療 /Cytokine&Growth Factor /hIL19/IL20/IL24 Triple Effector Reporter Cell

    hIL19/IL20/IL24 Triple Effector Reporter Cell

    CBP74223

    詢(xún) 價(jià)
    索取Protocol
    產(chǎn)品描述
    產(chǎn)品數據庫
    I. Background
    IL-19, IL-20, and IL-24 are closely related cytokines that belong to the IL-20 subfamily and play an important role in the protection of barrier tissues. They share the heterodimeric IL-20 type I and type II receptors composed of the IL-20Rα and IL-20Rβ chains, and IL-22Rα1 and IL-20Rβ chains, respectively.
     
    II. Introduction
    Expressed gene: hIL19/IL20/IL24
    Stability: 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
    Freeze Medium: 90% FBS+10% DMSO
    Culture Medium: N/A
    Mycoplasma Testing: Negative
    Storage: Liquid nitrogen
    Application(s): Functional(Report Gene) Assay
     
    III. Representative Data

    Figure 1. Dose Response of Ligands in hlL19/IL20/IL24 Triple Effector Reporter Cells (C16).

    Figure 2. Inhibition of Human lL20-induced Reporter Activity by hlL20 Neutralization Ab in hlL19/lL20/IL24 Triple Effector Reporter Cells (C16).

     

    客服

    微信

    掃一掃,添加二維碼

    電話(huà)

    留言

    藥靶模型聯(lián)系方式: 華東銷(xiāo)售經(jīng)理(上海):18240630236 華東銷(xiāo)售經(jīng)理(上海、江蘇、安徽):15715191010 華中&華西銷(xiāo)售經(jīng)理:18071545918 華中&西南銷(xiāo)售經(jīng)理:13871580511 華北銷(xiāo)售經(jīng)理:18628311252 全國銷(xiāo)售經(jīng)理:13816461235
    診斷標準品聯(lián)系方式: 華東銷(xiāo)售經(jīng)理:15000320447 華北銷(xiāo)售經(jīng)理:18628311252 華中&華西銷(xiāo)售經(jīng)理:18071545918 華中&西南銷(xiāo)售經(jīng)理:13871580511 全國銷(xiāo)售經(jīng)理:13816461235

    掃二維碼

    立即提交
    国产亚洲精品a在线无码麻豆-国产日产欧洲无码视频无遮挡-国产又色又爽又黄刺激在线视频-国产高清中文手机在线观看-日本乱偷人妻中文字幕在线